NSR-RHO

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNSR-RHO
Drug Alias NameAAV-based rhodopsin gene therapy (NightstaRx)NSR-RHO
ClassificationBiologics
Mechanisms of ActionRhodopsin stimulants
TargetsRhodopsin
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNightstarTx Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNightstarTx Ltd
Active IndicationsN/A
Inactive IndicationsRetinitis Pigmentosa

Other Information

ATC CodeN/A
Related LinksN/A